Atreca
Atreca researches, discovers, develops and commercializes novel immunotherapies for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 51-200
Industries / Tags:
Detailed Atreca Information
Geographic Data
Address: 500 Saginaw Drive
City: Redwood City
State: CA
Zip: 94063
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$125M
Raised Total:$348M
Social
Metrics
3,836,572Website Global Rank
3,300Website Monthly Traffic
Twitter Followers
Description
Atreca researches, discovers, develops and commercializes novel immunotherapies for the treatment of cancer.
Contact Phone:
+16505952595
Contact Email:
Atreca went public on 6/20/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/20/2019
IPO Valuation:
$388M
Ticker Symbol:
BCEL
IPO Price:
$17/share
Amount Raised:
$125M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
